Table 1.

Demographics of the patients before transepithelial re-crosslinking.

Patient	Sex	Age, years	Eye	Time of progression after primary CXL, months	Increase in Kmax, D	Protocol of Primary CXL	AC
1	M	15	OD	11	4.5	Standard iontophoresis, 9 mW/cm2,10 min	Y
			OS	11	2.3
2	F	19	OS	54	8.8	Epi-off, 9 mW/cm2,10 min	Y
3	F	18	OD	48	13.0	Standard iontophoresis, 9 mW/cm2,10 min	Y
			OS	48	12.1
4	M	17	OS	9	5.2	Transepithelial KXL system, 45 mW/cm2, 5 min and 20 s	Y
5	M	17	OD	16	3.8	Standard iontophoresis, 9 mW/cm2, 10 min	Y
			OS	16	2.6
6	M	16	OD	16	5.5	Transepithelial KXL system, 45 mW/cm2, 5 min and 20 s	Y
			OS	16	3.5
7	M	17	OD	22	4.7	Standard iontophoresis, 9 mW/cm2, 10 min	N
			OS	22	2.1
8	F	15	OD	12	2.5	Transepithelial KXL system, 45 mW/cm2, 5 min and 20 s	Y
			OS	12	2.2
9	F	20	OS	27	3.3	Epi-off, 9 mW/cm2, 10 min	Y
10	M	16	OD	19	1.9	Transepithelial KXL system, 45 mW/cm2, 5 min and 20 s	Y
			OS	19	1.3
11	M	21	OD	38	3.9	Epi-off, 9 mW/cm2,10 min	N
			OS	38	1.9
12	M	16	OD	15	1.7	Transepithelial KXL system, 45 mW/cm2, 5 min and 20 s	Y
			OS	15	2.6

CXL corneal collagen crosslinking, AC allergic conjunctivitis.